GlassScriptPhysician profile
Peter D'Orsaneo
NPI 1093329872
$2,252.06
in general payments reported to CMS, 2019-2025
15 companies · $1,883 in 2025
The $1,883 reported for 2025 was more than what 93% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $71.85 · 2023: $31.78 · 2024: $266 · 2025: $1,883.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,180.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $774.35 | 2024-2025 | Dovato, Rukobia, Apretude |
| Gilead Sciences, INC. | $608.78 | 2024-2025 | Biktarvy |
| Abbvie INC. | $292.24 | 2024-2025 | |
| Theratechnologies INC. | $101.04 | 2025 | Trogarzo, Egrifta |
| Janssen Scientific Affairs, LLC | $71.85 | 2022 | |
| Hologic Sales and Service, LLC | $65.87 | 2024-2025 | Aptima |
| Exact Sciences Corporation | $57.44 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $53.63 | 2025 | Repatha |
| Merck Sharp & Dohme LLC | $52.31 | 2025 | Pifeltro |
| Otsuka America Pharmaceutical, INC. | $48.25 | 2024-2025 | Rexulti |
| Novo Nordisk INC | $39.79 | 2025 | Wegovy |
| Napo Pharmaceuticals INC | $33.81 | 2025 | Mytesi |
| Esperion Therapeutics, INC. | $20.36 | 2025 | Nexletol |
| Teva Pharmaceuticals USA, INC. | $18.42 | 2025 | Austedo Xr |
| Pfizer INC. | $13.92 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter D'Orsaneo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.